Articles 2012
-
Joly, Y., et al. “Open Science and Community Norms: Data Retention and Publication Moratoria Policies in Genomics Projects” 12:2 (2012) Medical Law International, 92-120.
-
Romeo-Casabona, C., Nicolas, P., Knoppers, B.M., Joly, Y. et al., “Legal Aspects of Genetic Databases for International Biomedical Research: The Example of the International Cancer Genome Consortium (ICGC)” 37 (2012) Law and the Human Genome Review 15-34.
-
Dove, E.S., Ozdemir, V., Joly, Y., “Harnessing Omics Sciences, Population Databases, and Open Innovation Models for Theranostics‐Guided Drug Discovery and Development” 73:7 (2012) Drug Development Research, 439-446.
-
Joly, Y., et al., “Data Sharing in the Post-Genomic World: the Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO)” PLoS Computational Biology 8:7 (2012) PLoS Computational Biology, 1-5.
-
Dove, E.S., Joly, Y., Knoppers, B.M., “Power to the People: A Wiki Governance Model for Biobanks” 13 (2012) Genome Biology, 1-8.
-
Dove, E.S., Joly, Y., “The Contested Futures of Biobanks and Intellectual Property” 11 (2012) Teoria y Derecho, 132-146.
-
Harmon, S.H.E., Caulfield, T., Joly, Y., “Commercialisation versus Open Science: Making Sense of the Message(s) in the Bottle” 12:1 (2012) Medical Law International, 3-10.
-
Joly, Y., Allen, C., Knoppers, B.M., “Currents in Contemporary Bioethics. Open Access as Benefit Sharing? The Example of Publicly Funded Large-Scale Genomic Databases” 40:1 (2012) Journal of Law Medicine and Ethics, 143-146.
-
Caulfield, T., Harmon, S.H.E., Joly, Y., “Open Science versus Commercialization: A Modern Research Conflict?” 4:2 (2012) Genome Medicine, 1-11.
-
Ozdemir, V., Joly, Y. [...] Knoppers, B.M., “Are We Asking the Right Ethics Questions on Drug Shortages? Suggestions for a Global and Anticipatory Ethics Framework” 12:1 (2012) The American Journal of Bioethics, 13-15.